22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
October 20 2021 - 9:20AM
22nd Century Group, Inc. (Nasdaq: XXII), a leading
agricultural biotechnology company focused on tobacco harm
reduction, reduced nicotine tobacco and improving health and
wellness through plant science, will host a live webcast on
Thursday, November 4, 2021, at 10:00 AM ET to discuss its 2021
third quarter results. 22nd Century will report the Company’s third
quarter 2021 results in a press release at 6:00 AM ET the same day.
During the webcast, James A. Mish, chief executive officer;
Michael Zercher, chief operating officer; and John Franzino, chief
financial officer, will review third quarter results and discuss
progress made in each of the Company’s three franchises.
Following prepared remarks by management and slide presentation,
the Company will host a Q&A session, during which management
will accept questions from interested analysts. Investors,
shareholders, and members of the media will also have the
opportunity to pose questions to management by submitting questions
through the interactive webcast during the event.
The live and archived webcast, interactive Q&A and slide
presentation will be accessible on the Events web page in the
Company's Investor Relations section of the website, at
www.xxiicentury.com/investors/events. Please access the website at
least 15 minutes prior to the start of the webcast to register and,
if necessary, download and install any required software.
About 22nd Century Group, Inc.22nd Century
Group, Inc. (Nasdaq: XXII) is a leading agricultural
biotechnology company focused on tobacco harm reduction, reduced
nicotine tobacco and improving health and wellness through plant
science. With dozens of patents allowing it to control nicotine
biosynthesis in the tobacco plant, the Company has developed its
proprietary reduced nicotine content (RNC) tobacco plants and
cigarettes, which have become the cornerstone of the FDA’s
Comprehensive Plan to address the widespread death and disease
caused by smoking. In tobacco, hemp/cannabis, and hop plants, 22nd
Century uses modern plant breeding technologies, including genetic
engineering, gene-editing, and molecular breeding, to deliver
solutions for the life science and consumer products industries by
creating new, proprietary plants with optimized alkaloid and
flavonoid profiles as well as improved yields and valuable
agronomic traits.
Learn more at xxiicentury.com, on
Twitter @_xxiicentury, and on LinkedIn.
Cautionary Note Regarding Forward-Looking
StatementsExcept for historical information, all of the
statements, expectations, and assumptions contained in this press
release are forward-looking statements. Forward-looking statements
typically contain terms such as “anticipate,” “believe,”
“consider,” “continue,” “could,” “estimate,” “expect,” “explore,”
“foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,”
“potential,” “predict,” “preliminary,” “probable,” “project,”
“promising,” “seek,” “should,” “will,” “would,” and similar
expressions. Actual results might differ materially from those
explicit or implicit in forward-looking statements. Important
factors that could cause actual results to differ materially are
set forth in “Risk Factors” in the Company’s Annual Report on Form
10-K filed on March 11, 2021. All information provided in this
release is as of the date hereof, and the Company assumes no
obligation to and does not intend to update these forward-looking
statements, except as required by law.
Investor Relations & Media Contact:Mei
KuoDirector, Communications & Investor Relations22nd Century
Group, Inc.(716) 300-1221mkuo@xxiicentury.com
22nd Century (NASDAQ:XXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
22nd Century (NASDAQ:XXII)
Historical Stock Chart
From Sep 2023 to Sep 2024